JP2007533706A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007533706A5 JP2007533706A5 JP2007508906A JP2007508906A JP2007533706A5 JP 2007533706 A5 JP2007533706 A5 JP 2007533706A5 JP 2007508906 A JP2007508906 A JP 2007508906A JP 2007508906 A JP2007508906 A JP 2007508906A JP 2007533706 A5 JP2007533706 A5 JP 2007533706A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- ciclesonide
- dione
- diene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 claims description 8
- 229960003728 ciclesonide Drugs 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims 10
- 239000000825 pharmaceutical preparation Substances 0.000 claims 10
- 229940127557 pharmaceutical product Drugs 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 9
- -1 cyclohexylmethylene Chemical group 0.000 claims 6
- 208000006673 asthma Diseases 0.000 claims 4
- QIEPWCSVQYUPIY-LEKSSAKUSA-N Delta(1)-progesterone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 QIEPWCSVQYUPIY-LEKSSAKUSA-N 0.000 claims 3
- 239000003380 propellant Substances 0.000 claims 3
- 230000000391 smoking effect Effects 0.000 claims 3
- YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 claims 2
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 2
- 235000019504 cigarettes Nutrition 0.000 claims 2
- 239000006184 cosolvent Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010039083 rhinitis Diseases 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical group O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 claims 1
- 206010003557 Asthma exercise induced Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010014561 Emphysema Diseases 0.000 claims 1
- 208000004657 Exercise-Induced Asthma Diseases 0.000 claims 1
- 206010057190 Respiratory tract infections Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims 1
- 206010047924 Wheezing Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 206010006451 bronchitis Diseases 0.000 claims 1
- 125000000837 carbohydrate group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000024695 exercise-induced bronchoconstriction Diseases 0.000 claims 1
- 229960001021 lactose monohydrate Drugs 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000011269 treatment regimen Methods 0.000 claims 1
- 208000011479 upper respiratory tract disease Diseases 0.000 claims 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56346404P | 2004-04-20 | 2004-04-20 | |
| PCT/EP2005/051718 WO2005102354A1 (en) | 2004-04-20 | 2005-04-19 | Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007533706A JP2007533706A (ja) | 2007-11-22 |
| JP2007533706A5 true JP2007533706A5 (https=) | 2012-08-09 |
Family
ID=34967481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007508906A Pending JP2007533706A (ja) | 2004-04-20 | 2005-04-19 | 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070134165A1 (https=) |
| EP (1) | EP1740188A1 (https=) |
| JP (1) | JP2007533706A (https=) |
| AU (1) | AU2005235384B2 (https=) |
| CA (1) | CA2563556C (https=) |
| WO (1) | WO2005102354A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11007150B2 (en) | 2011-08-18 | 2021-05-18 | Covis Pharma Gmbh | Pharmaceutical aerosol product for administration by oral or nasal inhalation |
| BR112015010842B1 (pt) | 2012-12-21 | 2021-03-30 | Boehringer Ingelheim Vetmedica Gmbh | Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos |
| LT3473255T (lt) | 2012-12-21 | 2022-03-10 | Boehringer Ingelheim Vetmedica Gmbh | Farmacinė vaisto forma, apimanti ciklezonidą |
| ES2759247T3 (es) | 2014-06-18 | 2020-05-08 | Boehringer Ingelheim Vetmedica Gmbh | Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0039123B1 (en) * | 1980-02-27 | 1984-10-03 | TATE & LYLE PUBLIC LIMITED COMPANY | Crystalline glucose and process for its production |
| US4816445A (en) * | 1984-06-21 | 1989-03-28 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Crystalline alpha-maltose |
| JP2518646B2 (ja) * | 1987-05-29 | 1996-07-24 | 株式会社 林原生物化学研究所 | マルト−ス粉末の製造方法 |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US6536427B2 (en) * | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
| US5178866A (en) * | 1990-03-23 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug to the intestine |
| GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
| US5434304A (en) * | 1990-09-26 | 1995-07-18 | Aktiebolaget Astra | Process for preparing formoterol and related compounds |
| AU650953B2 (en) * | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
| US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| US6866839B2 (en) * | 1991-04-05 | 2005-03-15 | Sepracor Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| CA2111002C (en) * | 1991-06-10 | 2000-08-22 | Julianne Fassberg | Non-chlorofluorocarbon aerosol formulations |
| IT1250691B (it) * | 1991-07-22 | 1995-04-21 | Giancarlo Santus | Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac. |
| DK0701565T3 (da) * | 1993-04-02 | 1999-07-12 | Byk Gulden Lomberg Chem Fab | Nye prednisolonderivater |
| US5811388A (en) * | 1995-06-07 | 1998-09-22 | Cibus Pharmaceutical, Inc. | Delivery of drugs to the lower GI tract |
| ES2247604T3 (es) * | 1995-06-12 | 2006-03-01 | G.D. SEARLE & CO. | Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa. |
| AU7095296A (en) * | 1995-09-26 | 1997-04-17 | Takeda Chemical Industries Ltd. | Phosphorylamides, their preparation and use |
| US6380222B2 (en) * | 1996-10-11 | 2002-04-30 | Astrazeneca Ab | Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps |
| FR2754712B1 (fr) * | 1996-10-17 | 1999-09-03 | Merck Sharp Dohme Chibret Lab | Compositions ophtalmiques |
| US6613795B2 (en) * | 1996-11-11 | 2003-09-02 | Christian Noe | Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments |
| SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| US20020111495A1 (en) * | 1997-04-04 | 2002-08-15 | Pfizer Inc. | Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
| US6120752A (en) * | 1997-05-21 | 2000-09-19 | 3M Innovative Properties Company | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
| GB2329939A (en) * | 1997-06-26 | 1999-04-07 | Glaxo Group Ltd | Self-lubricating valve stem for aerosol containers |
| SE9704186D0 (sv) * | 1997-11-14 | 1997-11-14 | Astra Ab | New composition of matter |
| EP1054004B1 (en) * | 1997-12-15 | 2008-07-16 | Astellas Pharma Inc. | Novel pyrimidine-5-carboxamide derivatives |
| SE9801368D0 (sv) * | 1998-04-20 | 1998-04-20 | Astra Ab | New use |
| TWI243687B (en) * | 1998-04-21 | 2005-11-21 | Teijin Ltd | Pharmaceutical composition for application to mucosa |
| US6264923B1 (en) * | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
| US6241969B1 (en) * | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| ES2234266T3 (es) * | 1998-07-24 | 2005-06-16 | Jago Research Ag | Formulaciones medicas para aerosoles. |
| JP4672143B2 (ja) * | 1998-08-04 | 2011-04-20 | ヤゴテック アーゲー | 医薬用エーロゾル製剤 |
| PL200941B1 (pl) * | 1998-11-13 | 2009-02-27 | Jagotec Ag | Suchy proszkowy preparat inhalacyjny |
| US6397838B1 (en) * | 1998-12-23 | 2002-06-04 | Battelle Pulmonary Therapeutics, Inc. | Pulmonary aerosol delivery device and method |
| US6124268A (en) * | 1999-02-17 | 2000-09-26 | Natreon Inc. | Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof |
| IL146034A0 (en) * | 1999-04-23 | 2002-07-25 | Battelle Memorial Institute | High mass transfer electrosprayer |
| AU777167B2 (en) * | 1999-04-23 | 2004-10-07 | Battelle Memorial Institute | Directionally controlled EHD aerosol sprayer |
| AR026072A1 (es) * | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa |
| DE10062712A1 (de) * | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
| US20020183292A1 (en) * | 2000-10-31 | 2002-12-05 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and corticosteroids |
| US6528527B2 (en) * | 2000-11-07 | 2003-03-04 | Merck & Co., Inc. | Method of treatment with a combination of a PDE4 inhibitor and a leukotriene antagonist |
| CZ305498B6 (cs) * | 2000-12-22 | 2015-11-04 | Glaxo Group Limited | Kontejner a balení zahrnující inhalátor odměřených dávek |
| WO2003035030A1 (en) * | 2001-10-24 | 2003-05-01 | Pari Gmbh | Kit for the preparation of a pharmaceutical composition |
| KR20050044503A (ko) * | 2001-11-17 | 2005-05-12 | 아벤티스 파마 리미티드 | 흡착제 및 이의 용도 |
| CA2467652A1 (en) * | 2001-11-19 | 2003-05-30 | Altana Pharma Ag | Reversible proton pump inhibitors for the treatment of airway disorders |
| ITMI20020808A1 (it) * | 2002-04-17 | 2003-10-17 | Chiesi Farma Spa | Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione |
| EP3513813A1 (en) * | 2002-07-02 | 2019-07-24 | Astrazeneca | Ciclesonide-containing sterile aqueous suspension |
| PT1670482E (pt) * | 2003-09-16 | 2014-03-12 | Takeda Gmbh | Utilização de ciclesonida para o tratamento de doenças respiratórias |
-
2005
- 2005-04-19 US US11/578,294 patent/US20070134165A1/en not_active Abandoned
- 2005-04-19 EP EP05742781A patent/EP1740188A1/en not_active Ceased
- 2005-04-19 WO PCT/EP2005/051718 patent/WO2005102354A1/en not_active Ceased
- 2005-04-19 CA CA2563556A patent/CA2563556C/en not_active Expired - Fee Related
- 2005-04-19 JP JP2007508906A patent/JP2007533706A/ja active Pending
- 2005-04-19 AU AU2005235384A patent/AU2005235384B2/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100523541B1 (ko) | 유기 화합물 | |
| EP1603565B1 (en) | Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients | |
| Edsbäcker et al. | Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids? | |
| NO328698B1 (no) | Anvendelse av mometasonfuroat for fremstilling av et torrpulverinhaleringsmedikament for behandling av sykdommer i de ovre eller nedre luftveier eller lunger | |
| CA2496699A1 (en) | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids | |
| JP2004500433A (ja) | チオトロピウムとブデソニドを含む組合せ医薬 | |
| JP2007505829A5 (https=) | ||
| JP2004500430A (ja) | ホルモテロール及びブデソニドを含有する医薬用の組み合わせ | |
| HRP20140257T1 (hr) | Uporaba ciklesonida za lijeäśenje bolesti dišnih puteva | |
| CN106470700A (zh) | 用于治疗copd的噻托溴铵、福莫特罗和布地奈德的组合 | |
| US20130125882A1 (en) | Method and composition for treating asthma and copd | |
| ES2426957T3 (es) | Procedimiento de tratamiento de rinosinusitis aguda | |
| JP2007533706A5 (https=) | ||
| JP2007524698A5 (https=) | ||
| JP2004500434A (ja) | サルメテロールとブデソニドを含む組合せ医薬 | |
| EP1720577A2 (en) | Ciclesonide and glycopyrronium combination | |
| CN104271112A (zh) | 包含阿福特罗和糠酸氟替卡松的药物组合物 | |
| CN1306429A (zh) | 糖皮质类固醇在制备治疗轻度/早期c opd(慢性阻塞性肺病)的药物中的应用 | |
| US20070134165A1 (en) | Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient | |
| MXPA00009981A (en) | Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease) |